98%
921
2 minutes
20
Background: Canada has produced 16 national Report Cards on the Physical Activity of Children and Youth over the past 20 years. This manuscript details the impact of the most recent Report Cards released between 2015 and 2024, updating evidence since the publication of the impact paper focused on the first 10 years (2005-2014).
Methods: Various quantitative and qualitative approaches were employed to catalogue the developmental history and background of the Report Card, its leadership and sources of funding; consolidate and discuss the various evaluations and assessments that have been performed on the Report Card from 2015 to 2024; describe the distribution and reach of the Report Card from 2015 to 2024; and, examine the multi-dimensional impact of the Report Card on propelling the movement to get children and youth moving over the past 10 years in Canada and internationally.
Results: Leadership by ParticipACTION has led to replicating the Children and Youth Report Card in over 70 jurisdictions, with many examples of beneficial cross-fertilization of ideas across jurisdictions and sectors. The multisectoral impact of the Report Card in Canada continues to be substantial, though sustained funding remains a challenge. There is modest evidence that grades for some indicators are drifting upwards. Deliberate efforts have been made to better integrate evidence and gaps related to the physical activity of equity-denied groups.
Conclusions: Over the past 10 years, the ParticipACTION Children and Youth Report Card has continued to have a measurable, positive impact on the pediatric physical activity field in Canada (and beyond).
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11803841 | PMC |
http://dx.doi.org/10.1016/j.jesf.2025.01.005 | DOI Listing |
Hypertens Res
September 2025
Cardiovascular, Renal, Metabolism Epidemiology, BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK.
This study examined trends in the proportion of adults with self-reported hypertension and in antihypertensive medication use among community-dwelling Australian adults. We analysed data from a longitudinal panel study, covering four waves: 2009 (n = 8023), 2013 (n = 11,475), 2017 (n = 12,843), and 2021 (n = 14,571) for adults aged 18-74 years. Hypertension and antihypertensive medication use were self-reported.
View Article and Find Full Text PDFActa Parasitol
September 2025
Région du Centre, Université Joseph Ki-Zerbo, Rue Thomas Sankara, O3 BP 7021, Ouagadougou, Burkina Faso.
Introduction: The objective of the World Health Organization is to achieve the interruption of human African trypanosomiasis (HAT) transmission by 2030.
Methods: This review aims to update knowledge on HAT, through a synthesis on the epidemiology, diagnostic tools and drugs of HAT.
Results: From 1960 to 2024 approximately 132,063 cases of HAT have been reported across Africa.
J Interv Card Electrophysiol
September 2025
Federal University of Minas Gerais, R. Alfredo Balena, 190, Santa Efigênia, Belo Horizonte, Brazil.
Background: Chagas heart disease (ChD) is a significant public health concern in Latin America, contributing to a high incidence of sudden cardiac death (SCD). Despite advances in heart failure treatment, management of Chagas cardiomyopathy has not progressed accordingly. While ICDs are effective for primary and secondary prevention in other conditions, patients with ChD often experience more frequent episodes of ventricular tachycardia, and ICD use may provide a negative impact and increase mortality.
View Article and Find Full Text PDFJ Interv Card Electrophysiol
September 2025
School of Medicine and Health, Department of Clinical Medicine-Clinical Department for Cardiology, University Medical Centre, Technical University of Munich, Munich, Germany.
J Innov Card Rhythm Manag
August 2025
Cardiology Division, Hamilton Health Sciences, Arrhythmia Service Unit, McMaster University, Hamilton, ON, Canada.
We present a case of a 71-year-old woman with symptomatic paroxysmal atrial fibrillation and atypical atrial flutter (AFL), ultimately diagnosed with a rare type 3 macro-re-entrant biatrial tachycardia (BiAT). Despite initial pulmonary vein isolation and anterior line ablation for atypical AFL, she experienced recurrent AFL requiring a complex redo ablation. Successful termination of the tachycardia was achieved by extending ablation to the septal regions of both atria.
View Article and Find Full Text PDF